Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria

Lisätietoja

Funding Information:
The authors acknowledge the physicians and nurses at each FinnDiane center (Table S7 ) participating in the collection of the patient data. We also thank Hanna Olanne (Folkhälsan Research Center, Helsinki, Finland), Heli Krigsman (Folkhälsan Research Center, Helsinki, Finland), and Helinä Perttunen‐Nio (University of Helsinki, Helsinki, Finland) for their skilled laboratory work. This work was supported by grants from the Folkhälsan Research Foundation; the Wilhelm and Else Stockmann Foundation; the Medical Society of Finland; the Finnish Diabetes Research Foundation; the Liv och Hälsa Society; the Finnish Foundation for Cardiovascular Research; the Waldemar von Frenckell Foundation; the Finnish Kidney Foundation; the Dorothea Olivia, Karl Walter, and Jarl Walter Perklén Foundation; the Academy of Finland (grant numbers 316664 and 299200); the Signe and Ane Gyllenberg Foundation; the Sigrid Juselius Foundation; the Novo Nordisk Foundation (NNF, OC0013659); the Päivikki and Sakari Sohlberg Foundation; and by an EVO governmental grant (TYH2018207).

Publisher Copyright:
© 2021 The Association for the Publication of the Journal of Internal Medicine